Last reviewed · How we verify
CITUS Dry Syrup
CITUS Dry Syrup is a medication that works by inhibiting the action of a specific enzyme.
CITUS Dry Syrup is a medication that works by inhibiting the action of a specific enzyme. Used for Treatment of chronic hepatitis C virus infection.
At a glance
| Generic name | CITUS Dry Syrup |
|---|---|
| Sponsor | SamA Pharmaceutical Co., Ltd |
| Drug class | Antiviral |
| Target | NS5B polymerase |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
CITUS Dry Syrup is a prodrug that is converted into its active form, which then inhibits the enzyme responsible for the production of a certain compound. This inhibition leads to a decrease in the production of this compound, resulting in the therapeutic effect of CITUS Dry Syrup.
Approved indications
- Treatment of chronic hepatitis C virus infection
Common side effects
- Nausea
- Headache
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |